Patents
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
05/2014
05/28/2014EP2734232A1 Sequential anti - ctla4 and targeted il-2 therapy
05/28/2014EP2734231A1 Dosage of dnak
05/28/2014EP2734230A1 Recombinant feline leukemia virus vaccine containing optimized feline leukemia virus envelope gene
05/28/2014EP2734229A1 Methods and copositions for vaccinating against staphylococcus aureus
05/28/2014EP2734228A1 Fty720 increases cd74 expression and sensitizes cancer cells to anti-cd74 antibody-mediated cell death
05/28/2014EP2734227A2 Vaccine
05/28/2014EP2734226A2 Peptides shared among lethal cancers and therapeutic compositions comprising said peptides
05/28/2014EP2734225A1 Compositions having means for targeting at least one antigen to dendritic cells
05/28/2014EP2734221A1 Methods for diagnosing and treating alzheimer's disease by administering an angiogenic agent
05/28/2014EP2734199A1 Synthetic lethality and the treatment of cancer
05/28/2014CN103827300A 异源二聚化多肽 Heterologous polypeptide dimerization
05/28/2014CN103827143A 抗cd20抗体和抗gm-csf抗体的治疗性组合产品及其用途 Antibodies and anti-anti-cd20 gm-csf antibody therapeutic compositions of products and their uses
05/28/2014CN103826658A 具有氢氧化铝纳米颗粒的疫苗组合物 The vaccine composition of aluminum hydroxide having a nano-particles
05/28/2014CN103826657A 改进疫苗免疫原性的方法 Ways to improve vaccine immunogenicity
05/28/2014CN103826656A 金黄色葡萄球菌抗原的稳定的免疫原性组合物 Stabilized immunogenic composition of Staphylococcus aureus antigen
05/28/2014CN103826629A 恶性血液病的组合治疗 Combination therapy of hematological malignancies
05/28/2014CN103826623A 合成致死与癌症的治疗 Synthesis and treatment of cancer death
05/28/2014CN103826613A 疏水性制剂 Hydrophobic agents
05/28/2014CN103820528A Reelin及其拮抗剂在骨髓瘤患者分期及预后中的新应用 Reelin its antagonist new applications in staging and prognosis of patients with myeloma
05/28/2014CN103820515A 制备抗体F(ab')<sub>2</sub>片段的方法 The method of preparing an antibody F (ab ') <sub> 2 </ sub> fragment
05/28/2014CN103820483A 表达α-gal表位的卵巢癌干细胞疫苗及其制备方法 Expression of α-gal epitope ovarian cancer stem cell vaccine and its preparation method
05/28/2014CN103820472A 用于食管癌防治的hpv16,18l1重组dna疫苗 Hpv16,18l1 recombinant dna vaccine for the prevention of esophageal cancer
05/28/2014CN103820459A 一种能预防禽流感的藻类饲料与应用 Algae feed and Application of a can prevent avian influenza
05/28/2014CN103820399A 一种猪流行性腹泻病毒及其应用 Pig epidemic diarrhea virus and its application
05/28/2014CN103820398A 一种水貂肠炎病毒重组亚单位疫苗及其制备方法 One kind of mink enteritis virus recombinant subunit vaccine and its preparation method
05/28/2014CN103820397A 一种番鸭细小病毒及其应用 One kind of MDPV and its application
05/28/2014CN103820374A 引入人源cd24核苷酸序列的转化减毒李斯特菌及其疫苗 Human cd24 introduced nucleotide sequence and transformed attenuated Listeria vaccine
05/28/2014CN103819560A 抗cd79b抗体和免疫偶联物及使用方法 Antibodies and immunoconjugates of anti cd79b and methods of use thereof
05/28/2014CN103819559A 一种抗间皮素的纳米抗体及其编码基因和该纳米抗体的用途 Nanobodies its coding gene between an anti-mesothelin antibodies and the use of nano
05/28/2014CN103819558A Sclerostin结合剂 Sclerostin binding agents
05/28/2014CN103819543A 重组的人乳头瘤病毒6型l1蛋白及其用途 Recombinant human papillomavirus type 6 l1 protein and its use
05/28/2014CN103816541A ADP受体p2y12在血管生成中的应用 ADP receptor p2y12 application in angiogenesis
05/28/2014CN103816540A 降低β-抑制蛋白1与APH-1蛋白的结合的物质在制备防治神经退行性疾病药物中的应用 Reducing β- inhibit the binding protein 1 and the APH-1 protein substance prepared in the prevention and treatment of neurodegenerative diseases, drugs Application
05/28/2014CN103816537A 一种纳米佐剂及其制备方法 One kind Nami Zuo and preparation method
05/28/2014CN103816536A 抗猪萎缩性鼻炎和副猪嗜血杆菌病疫苗组合物及其制备 Anti-swine atrophic rhinitis and Haemophilus parasuis disease vaccine composition and preparation
05/28/2014CN103816535A 一种肿瘤疫苗及其制备方法 A cancer vaccine and its preparation method
05/28/2014CN103214578B 一种新型的人源化抗cd22抗体 A novel humanized antibody anti-cd22
05/28/2014CN103059139B 耐甲氧西林金黄色葡萄球菌(MRSA)疫苗重组蛋白抗原I<sub>12</sub>C及制备方法和应用 Methicillin-resistant Staphylococcus aureus (MRSA) vaccine recombinant protein antigens I <sub> 12 </ sub> C and preparation method and application
05/28/2014CN103007274B 一种鸡传染性支气管炎二价活疫苗 One kind of avian infectious bronchitis bivalent vaccine
05/28/2014CN102988972B 一种运用激流式生物反应器生产猪细小病毒灭活疫苗的方法 Setting a torrent bioreactor porcine parvovirus inactivated vaccine production methods
05/28/2014CN102973944B 一种含糖温度响应性蛋白质类药物载体的制备方法 Method for preparing sugar-temperature-responsive protein drug carrier
05/28/2014CN102876707B 一种重组脊髓灰质炎病毒Ⅰ型病毒样颗粒的制备方法 Preparation of a recombinant poliovirus type Ⅰ virus-like particles
05/28/2014CN102813918B 一种猪圆环病毒2型重组亚单位疫苗及其制备方法 A porcine circovirus type 2 recombinant subunit vaccine and its preparation method
05/28/2014CN102772796B O型口蹄疫病毒中含缅甸亚型的3个亚型基因工程多肽疫苗及其制备和用途 O-type FMD virus subtypes containing three subtypes of Myanmar genetically engineered peptide vaccine and its preparation and use
05/28/2014CN102631675B 一种高效CpG制剂及其制备方法和应用 An efficient CpG its preparation method and application
05/28/2014CN102516392B 一种癌靶向超抗原融合蛋白及制备方法及用途 In a cancer-targeted superantigen fusion protein and preparation method and uses
05/28/2014CN102504016B 淀粉样蛋白纤维性寡聚体构象型抗原表位多肽及其应用 Fibrous amyloid oligomers conformational epitope peptide and its application
05/28/2014CN102492038B 抗人Tim-3的中和性单克隆抗体L3D及其用途 Tim-3 anti-human neutralizing monoclonal antibodies and their use L3D
05/28/2014CN102462842B 板蓝根总多糖及其组分和它们作为疫苗佐剂的用途 Radix total polysaccharide and its components and their use as a vaccine adjuvant
05/28/2014CN102363042B 一种c型口蹄疫亚单位疫苗及其制备方法 One kind of c-type FMD subunit vaccine and its preparation method
05/28/2014CN102341499B 用于制备hpv疫苗和由其转化的重组乳酸菌的稳定组成型高表达载体 Hpv vaccine used in the preparation of its stability and conversion of constitutively high expression of recombinant lactobacillus vectors
05/28/2014CN102164962B 抗gd2抗体和方法及其相关应用 Antibodies and anti gd2 method and related applications
05/28/2014CN101796074B 抗刻缺蛋白1nrr抗体及其使用方法 Anti-Notch protein 1nrr antibodies and methods of use
05/28/2014CN101524534B 溶解和结合荚膜多糖的疫苗 Dissolved and combined vaccine capsular polysaccharide
05/28/2014CN101501058B 制备蛋白质材料的颗粒的方法 The method of preparation of protein material particles
05/27/2014USRE44916 Canine influenza virus and related compositions and methods of use
05/27/2014US8735553 Anti-PD1 antibodies and their use as therapeutics and diagnostics
05/27/2014US8735551 Antibodies for epidermal growth factor receptor 3 (HER3)
05/27/2014US8735543 Chimeric MOMP antigen
05/27/2014US8735542 HIV-1 clade a consensus sequences, antigens, and transgenes
05/27/2014US8735359 Combinations of modalities for the treatment of diabetes
05/27/2014US8735357 Method of inducing antigen-specific T cells
05/27/2014US8735355 Methods of use of fragments of secreted frizzled related protein, sFRP
05/27/2014US8735341 Non-viral delivery of compounds to mitochondria
05/27/2014US8735340 Conjugates that contain the homeodomain of antennapedia
05/27/2014US8735145 Property effecting and/or property exhibiting compositions for therapeutic and diagnostic uses
05/27/2014US8734815 Vaccine composition and immunization method
05/27/2014US8734814 Recombinant microorganisms and uses thereof
05/27/2014US8734813 Multivalent meningococcal polysaccharide-protein conjugate vaccine
05/27/2014US8734812 Neisserial antigenic peptides
05/27/2014US8734811 Methods and compositions for treating and preventing Shiga toxin-producing Escherichia coli infection
05/27/2014US8734810 Botulinum toxin treatments of neurological and neuropsychiatric disorders
05/27/2014US8734809 AAV's and uses thereof
05/27/2014US8734808 Isolation of a virus related to canine parvovirus-2 from a raccoon
05/27/2014US8734807 Preventing and curing Schistosomiasis mansoni by inhibiting Trk receptors on female Schistosoma
05/27/2014US8734806 Immunogenic composition and use thereof
05/27/2014US8734804 Treatment of myelosuppression
05/27/2014US8734803 Humanized neuraminidase antibody and methods of use thereof
05/27/2014US8734802 Methods of treating vasomotor symptoms using antibodies
05/27/2014US8734801 Anti-IL13 antibodies and uses thereof
05/27/2014US8734800 Subtypes of humanized antibody against interleukin-6 receptor
05/27/2014US8734798 Function modifying NAv 1.7 antibodies
05/27/2014US8734797 Anti-IL13 antibodies and uses thereof
05/27/2014US8734796 Carrier immunoglobulins
05/27/2014US8734795 Light targeting molecules and uses thereof
05/27/2014US8734794 Humanised antibodies to toll-like receptor 2 and uses thereof
05/27/2014US8734793 Recombinant antibodies against hepatitis C virus and methods of obtaining and using same
05/27/2014US8734792 Reagents and treatment methods for autoimmune diseases
05/27/2014US8734791 Optimized fc variants and methods for their generation
05/27/2014US8734790 Anti-TLR4 antibodies and methods of use thereof
05/27/2014US8734789 Targets for regulation of angiogenesis
05/27/2014US8734788 Composition and method for treatment of reperfusion injury and tissue damage
05/27/2014US8734783 Composition comprising probiotic bacteria for use in the treatment of immune disorders
05/27/2014US8734781 Method of preventing early Lawsonia intracellularis infections
05/27/2014US8734778 Yeast-based vaccines as immunotherapy
05/27/2014US8734776 Mutants of IL-29
05/27/2014CA2625992C Inhibition of placenta growth factor (p1gf) mediated metastasis and/or angiogenesis
05/27/2014CA2621373C Immunogenic complex formed by vaccinal antigens encapsulated by nanostructured mesoporous silica
05/27/2014CA2611816C Methods of purifying fc region containing proteins
05/27/2014CA2597698C Mycobacterial mutants affecting host apoptosis
1 ... 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 ... 1823